Transient life-threatening cerebral edema in a patient with systemic lupus erythematosus

Journal of Clinical Rheumatology

Volumn 15, Issue 4, 2009, Pages 181-184

  Bianchi, Matt T ^a   Lavigne, Catherine ^a   Sorond, Farzaneh ^b   Bermas, Bonnie ^c  

^a Partners Neurology   (United States)

^b MASSACHUSETTS GENERAL HOSPITAL   (United States)

^c BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

Blood brain barrier; Coma; Corticosteroids; Encephalopathy; Reversible

Indexed keywords

CORTICOSTEROID; CYCLOPHOSPHAMIDE; ENOXAPARIN; HYDROXYCHLOROQUINE; IMMUNOGLOBULIN; MANNITOL; METHYLPREDNISOLONE; PREDNISONE; RITUXIMAB; WARFARIN;

ADULT; ANEMIA; ARTICLE; ASEPTIC MENINGITIS; BRAIN DISEASE; BRAIN EDEMA; CASE REPORT; CEREBROSPINAL FLUID; COMPUTER ASSISTED TOMOGRAPHY; DEEP VEIN THROMBOSIS; DISEASE COURSE; DISEASE SEVERITY; DRUG DOSE REDUCTION; DRUG MEGADOSE; DRUG SUBSTITUTION; DRUG WITHDRAWAL; FEMALE; HEMOLYTIC ANEMIA; HUMAN; LETHARGY; LOW DRUG DOSE; MENTAL HEALTH; NEUTROPENIA; PANCYTOPENIA; PRIORITY JOURNAL; RECURRENT DISEASE; SUBARACHNOID HEMORRHAGE; SYSTEMIC LUPUS ERYTHEMATOSUS;

ADRENAL CORTEX HORMONES; BRAIN EDEMA; COMA; DECEREBRATE STATE; DIURETICS, OSMOTIC; FEMALE; HUMANS; IMMUNOGLOBULINS, INTRAVENOUS; LUPUS ERYTHEMATOSUS, SYSTEMIC; MANNITOL; MIDDLE AGED; RECURRENCE;

EID: 67650911593     PISSN: 10761608     EISSN: None     Source Type: Journal    
DOI: 10.1097/RHU.0b013e3181a64e9c     Document Type: Article

References (30)

1. Afeltra A, Garzia P, Mitterhofer AP, et al. Neuropsychiatric lupus syndromes: relationship with antiphospholipid antibodies. Neurology. 2003; 61:108-110.
2. Sofat N, Malik O, Higgens CS. Neurological involvement in patients with rheumatic disease. QJM. 2006;99:69-79.
3. Joseph FG, Lammie GA, Scolding NJ. CNS lupus: a study of 41 patients. Neurology. 2007;69:644-654.
4. Jennekens FG, Kater L. The central nervous system in systemic lupus erythematosus. Part 1. Clinical syndromes: a literature investigation. Rheumatology (Oxford). 2002;41:605-618.
5. Jennekens FG, Kater L. The central nervous system in systemic lupus erythematosus. Part 2. Pathogenetic mechanisms of clinical syndromes: a literature investigation. Rheumatology (Oxford). 2002;41:619 - 630.
6. Trysberg E, Tarkowski A. Cerebral inflammation and degeneration in systemic lupus erythematosus. Curr Opin Rheumatol. 2004;16:527-533.
7. The American College of Rheumatology nomenclature and case definitions for neuropsychiatric lupus syndromes. Arthritis Rheum. 1999;42: 599-608.
8. Hanly JG, McCurdy G, Fougere L, et al. Neuropsychiatric events in systemic lupus erythematosus: attribution and clinical significance. J Rheumatol. 2004; 31:2156-2162.
9. Sherer Y, Gorstein A, Fritzler MJ, et al. Autoantibody explosion in systemic lupus erythematosus: more than 100 different antibodies found in SLE patients. Semin Arthritis Rheum. 2004;34:501-537.
10. Golloub CA, Marcelo NC, Leahy W. Reversible profound neurologic deficits associated with transient cranial CT abnormalities and systemic lupus ery-thematosus. South Med J. 1989;82(5):650-652.
11. Kaell AT, Shetty M, Lee BC, et al. The diversity of neurologic events in systemic lupus erythematosus. Prospective clinical and computed tomo-graphic classification of 82 events in 71 patients. Arch Neurol. 1986;43:273-276.
12. Wong KL, Woo EK, Yu YL, et al. Neurological manifestations of systemic lupus erythematosus: a prospective study. QJM. 1991;81:857-870.
13. Futrell N, Schultz LR, Millikan C. Central nervous system disease in patients with systemic lupus erythematosus. Neurology. 1992;42:1649-1657.
14. Brey RL, Holliday SL, Saklad AR, et al. Neuropsychiatric syndromes in lupus: prevalence using standardized definitions. Neurology. 2002;58:1214-1220.
15. Hanly JG, Fisk JD, McCurdy G, et al. Neuropsychiatric syndromes in patients with systemic lupus erythematosus and rheumatoid arthritis. J Rheumatol. 2005;32:1459-1466.
16. Eyanson S, Passo MH, Aldo-Benson MA, et al. Methylprednisolone pulse therapy for nonrenal lupus erythematosus. Ann Rheum Dis. 1980;39:377-380.
17. Di Iorio G, Picillo U, Santanelli P, et al. A case of diffuse lupus encepha-lopathy successfully treated with high-dose intravenous methylprednisolone. Ital J Neurol Sci. 1992;13:247-250.
18. Hanmer O, Saltissi D. Response of acute cerebral lupus in childhood to pulse methylprednisolone in reduced dosage. Ann Rheum Dis. 1986;45: 606-607.
19. Aydin N, Utku U, Huseyin Ozer TE. An uncommon central nervous system manifestation in systemic lupus erythematosus: the diffuse and symmetrical lesions of white matter. Eur J Neurol. 2000;7:585.
20. Prabhakaran S, Bramlage M, Edgar MA, et al. Overwhelming leukoenceph-alopathy as the only sign of neuropsychiatric lupus. J Rheumatol. 2005;32: 1843-1845.
21. Mimori A, Suzuki T, Hashimoto M, et al. Subarachnoid hemorrhage and systemic lupus erythematosus. Lupus. 2000;9:521-526.
22. Claassen J, Carhuapoma JR, Kreiter KT, et al. Global cerebral edema after subarachnoid hemorrhage: frequency, predictors, and impact on outcome. Stroke. 2002;33:1225-1232.
23. Petty MA, Lo EH. Junctional complexes of the blood-brain barrier: permeability changes in neuroinflammation. Prog Neurobiol. 2002;68:311-323.
24. Alexander JJ, Bao L, Jacob A, et al. Administration of the soluble complement inhibitor, Crry-Ig, reduces inflammation and aquaporin 4 expression in lupus cerebritis. Biochim Biophys Acta. 2003;1639:169-176.
25. Gunnarson E, Zelenina M, Aperia A. Regulation of brain aquaporins. Neuroscience. 2004;129:947-955.
26. Guo Q, Sayeed I, Baronne LM, et al. Progesterone administration modulates AQP4 expression and edema after traumatic brain injury in male rats. Exp Neurol. 2006;198:469-478.
27. Zaccagni H, Fried J, Cornell J, et al. Soluble adhesion molecule levels, neuro-psychiatric lupus and lupus-related damage. Front Biosci. 2004;9:1654 -1659.
28. Caselli RJ, Boeve BF, Scheithauer BW, et al. Nonvasculitic autoimmune inflammatory meningoencephalitis (NAIM): a reversible form of encephalop-athy. Neurology. 1999;53:1579-1581.
29. Lang B, Dale RC, Vincent A. New autoantibody mediated disorders of the central nervous system. Curr Opin Neurol. 2003;16:351-357.
30. de Vries HE, Kuiper J, de Boer AG, et al. The blood-brain barrier in neuroinflammatory diseases. Pharmacol Rev. 1997;49:143-155.